{
    "medicine_id": "35ea22da8d231fd7e33e55423d808cb6d09eacee",
    "platform_id": "DB04992",
    "metadata": {
        "name": "Potiga 50 mg 1 Tablet film coated",
        "composition": "50 mg 1 AP5346",
        "clinical_particulars": {
            "therapeutic_indications": "For the treatment of various forms of cancer",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Preclinical studies of the delivery of platinum to tumors in an animal model has shown that compared with oxaliplatin at equitoxic doses AP5346 delivers in excess of 16 times more platinum to the tumor An analysis of tumor DNA which is the main target for anti cancer platinum agents has shown that in excess of 13 times more platinum tumor DNA complexes were formed from AP5346 than oxaliplatin in these studies Results from preclinical efficacy studies conducted in the B16 and other tumor models have also shown that AP5346 is superior to oxaliplatin in inhibiting the growth of tumors",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}